Remicade (infliximab) - J&J
Begedina (begelomab) - Adienne
Jakafi (ruxolitinib) - Novartis, Incyte
Simulect (basiliximab) - Novartis
https://tandem.confex.com/tandem/2024/meetingapp.cgi/Paper/23774
 
David C. Shyr, MD1; Sebastian Fernandez-Pol, MD, PhD2; Steven Chirielesion, MD3; Katja G. Weinacht, MD, PhD4; Lyndsie Hiroshima, PharmD, BCPS, BCPPS5; Ami J. Shah, MD6; Rajni Agarwal, MD7; Karen Kristovich, RN PNP8; Elizabeth Callard, MSN, NP-BC, RN9; Michela Spinelli, PhD10; Renata Palmieri, Msc10; Antonio Di Naro, PhD, MBA10; Alice Bertaina, MD, PhD1
 
Dec 12, 2023
 
Prev Next